These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3906779)

  • 1. [Syntheses of [prolyl-U-14C]alacepril and its related compounds].
    Kagemoto A; Nakao M; Negoro T; Sekine Y; Hashimoto M
    Radioisotopes; 1985 Aug; 34(8):408-13. PubMed ID: 3906779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition and metabolism of the novel antihypertensive agent alacepril in rats.
    Matsumoto K; Miyazaki H; Fujii T; Yoshida K; Amejima H; Hashimoto M
    Arzneimittelforschung; 1986; 36(1):40-6. PubMed ID: 3513776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue levels, tissue angiotensin converting enzyme inhibition and antihypertensive effect of the novel antihypertensive agent alacepril in renal hypertensive rats.
    Nambu K; Matsumoto K; Takeyama K; Hosoki K; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986; 36(1):47-51. PubMed ID: 3006710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of protein conjugate of desacetyl-alacepril and its effect on angiotensin converting enzyme in renal hypertensive rats.
    Matsumoto K; Nambu K; Fujii T; Takeyama K; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986; 36(1):52-4. PubMed ID: 3006711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive mechanism of alacepril: effect on norepinephrine-induced vasoconstrictive response in vitro and in vivo.
    Takeyama K; Minato H; Ikeno A; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):74-7. PubMed ID: 3513780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 2nd communication: Effects on central nervous and sensory systems and on the other functions.
    Matsuno Y; Hori H; Oka M; Nakamura H; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):62-8. PubMed ID: 3513778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
    Takeyama K; Minato H; Nakatsuji K; Suzuki H; Nose I; Oka M; Hosoki K; Hatano N; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):69-73. PubMed ID: 3513779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.
    Hosoki K; Takeyama K; Minato H; Fukuya F; Kawahara S; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):77-83. PubMed ID: 3006712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive mechanism of alacepril. Effects of its metabolites on the peripheral sympathetic nervous system.
    Minato H; Hosoki K; Hayashi K; Sawayama T; Kadokawa T; Hashimoto M
    Arzneimittelforschung; 1989 Mar; 39(3):319-24. PubMed ID: 2547387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of the new oral angiotensin converting enzyme inhibitor 1-(D-3-acetylthio-2-methylpropanoyl)-L-prolyl-L-phenylalanine (Alacepril) in essential hypertension.
    Mizuno K; Hashimoto S; Kunii N; Tani M; Niimura S; Yabe R; Watari H; Fukuchi S
    Res Commun Chem Pathol Pharmacol; 1985 Aug; 49(2):175-87. PubMed ID: 2997886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antihypertensive treatment with alacepril on insulin resistance in diabetic spontaneously hypertensive rats.
    Sato T; Nara Y; Kato Y; Yamori Y
    Metabolism; 1996 Apr; 45(4):457-62. PubMed ID: 8609831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term plasma levels and dose modulation of alacepril in patients with chronic renal failure.
    Nonoguchi H; Kiyama S; Kitamura K; Naruse M; Tomita M; Tazoe N; Tajiri M; Nakayama Y; Kohda Y; Inoue T; Tomita K
    Hypertens Res; 2008 Jan; 31(1):29-36. PubMed ID: 18360015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of captopril and its mixed disulphides in plasma and urine by high-performance liquid chromatography.
    Hayashi K; Miyamoto M; Sekine Y
    J Chromatogr; 1985 Feb; 338(1):161-9. PubMed ID: 3894398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialic acid 9-O-acetylesterase catalyzes the hydrolyzing reaction from alacepril to deacetylalacepril.
    Usui S; Kubota M; Iguchi K; Kiho T; Sugiyama T; Katagiri Y; Hirano K
    Pharm Res; 2003 Aug; 20(8):1309-16. PubMed ID: 12948030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free radical scavenging properties of alacepril metabolites and lisinopril.
    Noda Y; Mori A; Packer L
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):125-36. PubMed ID: 9226747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alacepril and amlodipine on the renal injury induced by a high-cholesterol diet in rats.
    Atarashi K; Takagi M; Minami M; Ishiyama A
    J Hypertens; 1999 Dec; 17(12 Pt 2):1983-6. PubMed ID: 10703899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension.
    Ideishi M; Sasaguri M; Ikeda M; Arakawa K
    Clin Ther; 1989; 11(4):441-51. PubMed ID: 2550133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.